ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
The Lancet Oncology
◽
10.1016/s1470-2045(13)70586-2
◽
2014
◽
Vol 15
(2)
◽
pp. 143-155
◽
Cited By ~ 496
Author(s):
Martin Reck
◽
Rolf Kaiser
◽
Anders Mellemgaard
◽
Jean-Yves Douillard
◽
Sergey Orlov
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Small Cell Lung
◽
Phase 3
◽
Double Blind
◽
Previously Treated
◽
Randomised Controlled
Download Full-text
Related Documents
Cited By
References
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(16)32517-x
◽
2017
◽
Vol 389
(10066)
◽
pp. 255-265
◽
Cited By ~ 1731
Author(s):
Achim Rittmeyer
◽
Fabrice Barlesi
◽
Daniel Waterkamp
◽
Keunchil Park
◽
Fortunato Ciardiello
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Small Cell Lung
◽
Open Label
◽
Phase 3
◽
Previously Treated
◽
Randomised Controlled
Download Full-text
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(15)01281-7
◽
2016
◽
Vol 387
(10027)
◽
pp. 1540-1550
◽
Cited By ~ 2708
Author(s):
Roy S Herbst
◽
Paul Baas
◽
Dong-Wan Kim
◽
Enriqueta Felip
◽
José L Pérez-Gracia
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Small Cell Lung
◽
Previously Treated
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726044364.793539633
◽
2017
◽
Cited By ~ 2
Author(s):
Patrick Nana-Sinkam
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Small Cell Lung
◽
Previously Treated
◽
Randomised Controlled
Download Full-text
Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(14)61085-0
◽
2015
◽
Vol 385
(9962)
◽
pp. 36-42
◽
Cited By ~ 229
Author(s):
Ben J Slotman
◽
Harm van Tinteren
◽
John O Praag
◽
Joost L Knegjens
◽
Sherif Y El Sharouni
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Thoracic Radiotherapy
◽
Small Cell Lung
◽
Phase 3
◽
Extensive Stage
◽
Randomised Controlled
Download Full-text
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
The Lancet Oncology
◽
10.1016/s1470-2045(12)70063-3
◽
2012
◽
Vol 13
(3)
◽
pp. 247-255
◽
Cited By ~ 370
Author(s):
Luis Paz-Ares
◽
Filippo de Marinis
◽
Mircea Dediu
◽
Michael Thomas
◽
Jean-Louis Pujol
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Supportive Care
◽
Controlled Trial
◽
Best Supportive Care
◽
Small Cell
◽
Small Cell Lung
◽
Phase 3
◽
Double Blind
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718047126.793482089
◽
2013
◽
Author(s):
Thomas Stinchcombe
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Wild Type
◽
Small Cell Lung
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726215272.793539632
◽
2017
◽
Author(s):
Patrick Nana-Sinkam
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Controlled Trial
◽
Small Cell
◽
Phase 2
◽
Small Cell Lung
◽
Open Label
◽
Open Label Phase
◽
Previously Treated
◽
Randomised Controlled
Download Full-text
Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial
Annals of Oncology
◽
10.1093/annonc/mdz122
◽
2019
◽
Vol 30
(7)
◽
pp. 1114-1120
◽
Cited By ~ 13
Author(s):
R.Y. Tay
◽
F. Fernández-Gutiérrez
◽
V. Foy
◽
K. Burns
◽
J. Pierce
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Prognostic Value
◽
Controlled Trial
◽
Small Cell
◽
Circulating Tumour Cells
◽
Small Cell Lung
◽
Once Daily
◽
Randomised Controlled
Download Full-text
MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial
BMC Surgery
◽
10.1186/s12893-018-0359-6
◽
2018
◽
Vol 18
(1)
◽
Cited By ~ 12
Author(s):
Jelle E. Bousema
◽
◽
Marcel G. W. Dijkgraaf
◽
Nicole E. Papen-Botterhuis
◽
Hermien W. Schreurs
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Endoscopic Ultrasonography
◽
Study Protocol
◽
Cell Lung Cancer
◽
Controlled Trial
◽
Small Cell
◽
Small Cell Lung
◽
Randomised Controlled
Download Full-text
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
The Lancet Oncology
◽
10.1016/s1470-2045(20)30013-9
◽
2020
◽
Vol 21
(4)
◽
pp. 581-592
◽
Cited By ~ 14
Author(s):
Ursula Nestle
◽
Tanja Schimek-Jasch
◽
Stephanie Kremp
◽
Andrea Schaefer-Schuler
◽
Michael Mix
◽
...
Keyword(s):
Lung Cancer
◽
Randomised Controlled Trial
◽
Small Cell Lung Cancer
◽
Controlled Trial
◽
Locally Advanced
◽
Target Volume
◽
Small Cell
◽
Small Cell Lung
◽
Open Label
◽
Randomised Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close